<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
PACIFIC PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.02 PAR VALUE PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
69475 41 02
------------------------------
(CUSIP Number)
April 23, 1998
-------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter disclosure
provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
<PAGE>
CUSIP NO. 69475 41 02 13G
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lou Weisbach
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) / /
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
5 SOLE VOTING POWER
955,100
NUMBER
6 SHARED VOTING POWER
OF SHARES
0
BENEFICIALLY
OWNED BY 7 SOLE DISPOSITIVE POWER
EACH 955,100
REPORTING
8 SHARED DISPOSITIVE POWER
PERSON
0
WITH:
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
955,100
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
/ /
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9).
9.3%
12 TYPE OF REPORTING PERSON
IN
Page 2 of 6 Pages
<PAGE>
Item 1(a) Name of Issuer
--------------
Pacific Pharmaceuticals, Inc., a Delaware corporation
Item 1(b) Address of Issuer's Principal Executive Offices
-----------------------------------------------
6730 Mesa Ridge Road
Suite A
San Diego, California 92121
Item 2(a) Name of Person Filing
---------------------
Lou Weisbach (the "Reporting Person")
Item 2(b) Address of Principal Business Office or, if none, Residence
-----------------------------------------------------------
5980 West Touhy Avenue
Niles, Illinois 60714
Item 2(c) Citizenship
-----------
Illinois
Item 2(d) Title of Class of Securities
----------------------------
Common Stock, $.02 par value per share (the "Common Stock")
Item 2(e) CUSIP Number
------------
69475 41 02
Item 3 If this Statement is Filed Pursuant to
Rule 13d-1(b) or 13d-2(b) or (c)
--------------------------------
Not Applicable
Item 4 Ownership
---------
(a) Amount Beneficially Owned as of April 23, 1998:
955,100 shares of Common Stock
Page 3 of 6 Pages
<PAGE>
(b) Percent of Class:
Based on the Issuer's filing on Form 10-Q, dated February 13,
1998, there are an aggregate of 10,323,427 shares of Common Stock
issued and outstanding. As of April 23, 1998, the Reporting
Person beneficially owned 955,100 shares of Common Stock or
approximately 9.3% of the aggregate number of shares of Common
Stock issued and outstanding on such date.
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote:
955,100
(ii) shared power to vote or to direct the vote: 0
(iii)sole power to dispose or to direct the
disposition of: 955,100
(iv) shared power to dispose or to direct the disposition of: 0
Item 5 Ownership of Five Percent or Less of a Class
--------------------------------------------
Not Applicable
Item 6 Ownership of More Than Five
Percent on Behalf of Another Person
-----------------------------------
Not Applicable
Item 7 Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company
-----------------------------------------
Not Applicable
Item 8 Identification and Classification
of Members of the Group
-----------------------
Not Applicable
Page 4 of 6 Pages
<PAGE>
Item 9 Notice of Dissolution of Group
------------------------------
Not Applicable
Item 10 Certification
-------------
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
Page 5 of 6 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: April 23, 1998
/s/ Lou Weisbach
-------------------------------------------
Lou Weisbach
Page 6 of 6 Pages
